To investigate how BCL-2, BCL-XL, and MCL-1 affect resistance of AML cells to the selected agents, we examined isogenic cell lines with altered expression of the BCL-2, BCL-XL, and MCL-1 genes. This evidence concerns the gene BCL2 and acute myeloid leukemia.